Inhibikase Therapeutics, Inc.
www.inhibikase.comInhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Read more
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Read more
Country
State
Georgia
City (Headquarters)
Atlanta
Industry
Employees
1-10
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder , President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Board Member , Independent Director , Audit Committee Chair
Email ****** @****.comPhone (***) ****-****Director
Email ****** @****.comPhone (***) ****-****Head of Program Management
Email ****** @****.comPhone (***) ****-****
Technologies
(23)
